Related references
Note: Only part of the references are listed.Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen
Gregory N. Adams et al.
CANCER RESEARCH (2015)
Heparin in malignant glioma: review of preclinical studies and clinical results
Rosalie Schnoor et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells
Hooi Ching Lim et al.
MOLECULAR CANCER (2015)
The mechanisms of cancer-associated thrombosis
Anna Falanga et al.
THROMBOSIS RESEARCH (2015)
The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink
M. A. O'Rorke et al.
CANCER CAUSES & CONTROL (2015)
Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response
Elisabeth M. Battinelli et al.
BLOOD (2014)
Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling
Susanne A. Kuhn et al.
NEUROLOGICAL RESEARCH (2014)
Heparin blocks transfer of extracellular vesicles between donor and recipient cells
Nadia A. Atai et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
New insights into the mechanisms of venous thrombosis
Nigel Mackman
JOURNAL OF CLINICAL INVESTIGATION (2012)
Dabigatran Etexilate A New Oral Thrombin Inhibitor
Graeme J. Hankey et al.
CIRCULATION (2011)
Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b
Xiaokun Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Thrombin Induces Tumor Cell Cycle Activation and Spontaneous Growth by Down-Regulation of p27Kip1, in Association with the Up-Regulation of Skp2 and MiR-222
Liang Hu et al.
CANCER RESEARCH (2009)
Twist is required for thrombin-induced tumor angiogenesis and growth
Liang Hu et al.
CANCER RESEARCH (2008)
Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo
P. Mellor et al.
BRITISH JOURNAL OF CANCER (2007)
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
Joachim Stangier et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Increased incidence of neoplasia with persistent activation of the of the digestive tract in men coagulant pathway
GJ Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis
L Hu et al.
BLOOD (2004)
Human α-thrombin stimulates proliferation of interferon-γ differentiated, growth-arrested U937 cells, overcoming differentiation-related changes in expression of p21CIP1/WAF1 and cyclin D1
A Naldini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
S Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Thrombin inhibits tumor cell growth in association with up-regulation of p21waf/cip1 and caspases via a p53-independent, STAT-1-dependent pathway
YQ Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
